Company Overview
Snapshot
Founded in December 2014 by Isaac Litman, Neteera operates with 51–200 employees. The company has raised $36.4M across 5 funding rounds from 8 investors. In October 2023, Neteera secured an additional Series B extension round, with Aescuvest participating as a lead investor.
Business overview
Neteera specializes in enhancing patient care through its contactless monitoring solution, which delivers vital and activity metrics. The company's core technology, featuring a smart sensing platform powered by a maintenance-free micro-radar chip, is CE MDR & FDA-approved. Neteera serves hospitals, post-acute care facilities, and home care settings, providing real-time patient data and customizable alerts to healthcare staff. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Remote Monitoring.
Strategic signal
In October 2023, Neteera raised an additional $6.7 million in a Series B extension round. This funding, with Aescuvest as a lead investor, signals continued investor confidence in Neteera's contactless remote patient monitoring technology and its potential for market expansion within the health tech industry. It suggests a strategic focus on scaling operations and further developing its smart sensing platform for broader adoption in healthcare settings.
Company Intelligence Q&A
- What was a significant recent funding event for Neteera?
- In October 2023, Neteera raised an additional Series B extension round, with Aescuvest participating as a lead investor.
- When did Neteera secure its Series B funding?
- Neteera secured its Series B funding in April 2023, with Omega Healthcare Investors and Aescuvest participating.
- What was Neteera's involvement with CNBC's Disruptor 50 list?
- Neteera was named to CNBC's Disruptor 50 list in June 2020 and again in November 2021, recognizing its contactless vital signs monitoring technology.
- What was Neteera's response to the COVID-19 pandemic?
- In March 2020, Neteera launched a contactless vital signs sensing system for COVID-19 early screening and home care.
- Which investors participated in Neteera's Series A round?
- In March 2020, Neteera secured its Series A funding from Northwell Ventures and Ascend Capital Partners.